↓ Skip to main content

Dove Medical Press

Clinical utility of eslicarbazepine: current evidence

Overview of attention for article published in Drug Design, Development and Therapy, February 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
54 Mendeley
Title
Clinical utility of eslicarbazepine: current evidence
Published in
Drug Design, Development and Therapy, February 2015
DOI 10.2147/dddt.s57409
Pubmed ID
Authors

Gaetano Zaccara, Fabio Giovannelli, Massimo Cincotta, Alessia Carelli, Alberto Verrotti

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 2%
Portugal 1 2%
Switzerland 1 2%
Unknown 51 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 17%
Professor > Associate Professor 7 13%
Student > Ph. D. Student 7 13%
Researcher 6 11%
Professor 4 7%
Other 11 20%
Unknown 10 19%
Readers by discipline Count As %
Medicine and Dentistry 14 26%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Chemistry 5 9%
Neuroscience 4 7%
Psychology 3 6%
Other 8 15%
Unknown 15 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2017.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from Drug Design, Development and Therapy
#641
of 2,268 outputs
Outputs of similar age
#112,028
of 361,176 outputs
Outputs of similar age from Drug Design, Development and Therapy
#18
of 62 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,176 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.